Salvina Therapeutics is developing antibodies with a novel approach for targeting TNF and TNF superfamily members with the aim of improving their safety and efficacy, and facilitating the generation of novel bispecific therapies.
- Get directions
- Bookmark
- Share
- Report
- prev
- next
Location
-
Hegenheimermattweg 167A, 4123 Allschwil, Switzerland
Additional address info
- c/o Switzerland Innovation Park Basel Area
Canton
Facts & figures
-
Type of organizationPrivate company
-
Year of foundation2023
-
Number of employees in Switzerland1-9
Core competencies
You may also be interested in
Tridek-One Therapeutics SAS 
- R&D
Member
MicThera SAGL
- R&D
Member